Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-22-2026-05_46_48-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Commercial
  • The Top 15 Specialty Pharmacies of 2025: PBM-Affiliated Pharmacies Dominate While Health Systems and Independents Gain Ground
  • Commercial

The Top 15 Specialty Pharmacies of 2025: PBM-Affiliated Pharmacies Dominate While Health Systems and Independents Gain Ground

Drug Channels

By Adam J.

CommercialRead full story

pharminent April 21, 2026 (Last updated: April 21, 2026)

Drug Channels

By Adam J.

CommercialRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine
Next: Jazz and Lilly cancer drugs cleared for use by NHS

Related Stories

  • Commercial

Post-marketing oncology studies: Enabling faster recruitment and lower costs

pharminent June 22, 2026
  • Commercial

The first 14 days: How specialty programs set patients up for success

pharminent June 22, 2026
  • Commercial

Denali sells FDA voucher for $195M to support neurodegenerative pipeline

pharminent June 19, 2026

You May Have Missed

  • News

pharminent June 22, 2026
sample_feature_2026-06-22
  • News

AbbVie to Acquire Apogee Therapeutics for Nearly $11 Billion in Immunology Bet

pharminent June 22, 2026
  • M&A / Deals

AbbVie climbs post-Allergan M&A peak with Apogee buy

pharminent June 22, 2026
  • M&A / Deals

Lilly bets up to $800M for BioArctic’s brain delivery tech

pharminent June 22, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.